Cancer52 response to the NICE consultationPlease find here Cancer52's response to the NICE Methods of Technology Appraisal Consultation, which was submitted to NICE on Tuesday...
Clara Mackay appointed as interim chair of Cancer52Cancer52 is delighted to announce that Clara Mackay, Deputy CEO of Pancreatic Cancer UK, has been appointed as interim chair of Cancer52....